Acute myeloid leukemia: open trials in Russia

11 open trials have a site in Russia. Registry data; only the trial team decides who can take part.

NCT07303660
A Phase 1b Study of Lonitoclax + Azacitidine in Acute Myeloid Leukemia Patients
Trial Treatment · Phase 1 · Lomond Therapeutics Holdings, Inc.
Medsi group Joint Stock Company Clinical Hospital, Krasnogorsk · State Budgetary Institution of Healthcare S.P. Botkin Moscow Multidisciplinary Scientific and Clinical Center of the Moscow Health Department, Moscow · Federal State Budgetary Institution "Russian Research Institute of Hematology and Transfusiology of the Federal Medical and Biological Agency", Saint Petersburg · State Budgetary Healthcare Institution Leningrad Regional Clinical Hospital, Saint Petersburg · State Regional Budgetary Healthcare Institution "Novgorod Regional Clinical Hospital", Velikiy Novgorod
Registry updated 2026-08-31
NCT07366801
Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies
Trial Treatment · Phase 2/3 · Federal Research Institute of Pediatric Hematology, Oncology and Immunology
National medical research center of pediatric haematology, oncology and immulogy named after Dmytriy Rogachyov, Moscow, 117198, Moscow
Registry updated 2026-01-26
NCT07256210
Feasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse Prophylaxis After Hematopoietic Stem Cell Transplantation
Trial Treatment · Phase 2 · Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Dmitry Rogachev Federal Research and Clinical Centre of Paediatric Haematology, Oncology and Immunology, Moscow
Registry updated 2025-12-01
NCT06389292
A Pivotal Study of APG-2575 (Lisaftoclax) Combined With Azacitidine in the Treatment of Acute Myeloid Leukemia
Trial Treatment · Phase 3 · Ascentage Pharma Group Inc.
Moscow Multidisciplinary Clinical Center "Kommunarka", Moscow · Botkin Moscow Multidisciplinary Research and Clinical Center, Moscow · Leningrad regional clinical hospital, Saint Petersburg · Russian Research Institute of Hematology and Transfusiology of the Federal Medical and Biological Agency, Saint Petersburg
Registry updated 2025-11-25
NCT07232134
The Efficacy of Therapy in Patients With Acute Myeloid Leukemia and Down Syndrome in Russia
Trial Treatment · Phase 3 · Federal Research Institute of Pediatric Hematology, Oncology and Immunology
This trial only enrols participants with Down syndrome
National medical research center of pediatric haematology, oncology and immulogy named after Dmytriy Rogachyov, Moscow, 117198, Moscow
Registry updated 2025-11-20
NCT07238712
Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched Donor
Trial Treatment · Phase 2 · St. Petersburg State Pavlov Medical University
Pavlov University, Saint Petersburg
Registry updated 2025-11-20
NCT06756152
Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with Hemoblastosis
Trial Treatment · Phase 2/3 · Federal Research Institute of Pediatric Hematology, Oncology and Immunology
National medical research center of pediatric haematology, oncology and immulogy named after Dmytriy Rogachyov, Moscow
Registry updated 2025-01-01
NCT06532084
Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen
Trial Treatment · Phase 2 · St. Petersburg State Pavlov Medical University
RM Gorbacheva Research Institute, Saint Petersburg
Registry updated 2024-08-01
NCT06508099
Vitamin A and D Supplementation in Allogeneic HCT
Trial Treatment · Phase 2 · St. Petersburg State Pavlov Medical University
RM Gorbacheva Research Institute, Saint Petersburg
Registry updated 2024-07-31
NCT06477549
BeFluBu vs FluBuRux Conditioning in Haploidentical HCT
Trial Treatment · Phase 2 · St. Petersburg State Pavlov Medical University
RM Gorbacheva Research Institute, Saint Petersburg
Registry updated 2024-06-27
NCT06418776
IMPACT-AML: Randomized Pragmatic Clinical Trial for Relapsed or Refractory AML
Trial Treatment · Phase 3 · National Research Center for Hematology, Russia
National Research Center for Hematology, Moscow
Registry updated 2024-05-17

All Acute myeloid leukemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error